Viracta Therapeutics
VIRX
#9949
Rank
NZ$16.37 M
Marketcap
$0.41
Share price
10.74%
Change (1 day)
-48.13%
Change (1 year)

Viracta Therapeutics (VIRX) - Cash on Hand

Cash on Hand as of September 2024 : NZ$37.47 Million

According to Viracta Therapeutics's latest financial reports the company has NZ$37.47 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viracta Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$84.9 M-40.79%
2022-12-31NZ$0.14 B-5.42%
2021-12-31NZ$0.15 B132.31%
2020-12-31NZ$65.26 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.48 B 1,188.89%๐Ÿ‡บ๐Ÿ‡ธ USA